181 related articles for article (PubMed ID: 37296810)
1. Evaluation of Contrast-Enhanced Mammography and Development of Flowchart for BI-RADS Classification of Breast Lesions.
Klarić K; Šribar A; Budisavljević A; Labinac L; Valković Zujić P
Diagnostics (Basel); 2023 Jun; 13(11):. PubMed ID: 37296810
[TBL] [Abstract][Full Text] [Related]
2. Value of contrast-enhanced mammography combined with the Kaiser score for clinical decision-making regarding tomosynthesis BI-RADS 4A lesions.
Rong X; Kang Y; Xue J; Han P; Li Z; Yang G; Shi G
Eur Radiol; 2022 Nov; 32(11):7439-7447. PubMed ID: 35639141
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic performance of the Kaiser score in the evaluation of breast lesions on contrast-enhanced mammography.
Kang Y; Li Z; Yang G; Xue J; Zhang L; Rong X
Eur J Radiol; 2022 Nov; 156():110524. PubMed ID: 36126352
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the applicability of BI-RADS® MRI for the interpretation of contrast-enhanced digital mammography.
Travieso-Aja MM; Maldonado-Saluzzi D; Naranjo-Santana P; Fernández-Ruiz C; Severino-Rondón W; Rodríguez Rodríguez M; Luzardo OP
Radiologia (Engl Ed); 2019; 61(6):477-488. PubMed ID: 31262509
[TBL] [Abstract][Full Text] [Related]
5. Utility of MRI-Directed Contrast-Enhanced Mammography for Biopsy Planning for Suspicious MRI-Detected Breast Lesions.
Nida BA; Rooney TB; Miller MM
AJR Am J Roentgenol; 2023 Feb; 220(2):202-211. PubMed ID: 36000664
[No Abstract] [Full Text] [Related]
6. Low-Dose, Contrast-Enhanced Mammography Compared to Contrast-Enhanced Breast MRI: A Feasibility Study.
Clauser P; Baltzer PAT; Kapetas P; Hoernig M; Weber M; Leone F; Bernathova M; Helbich TH
J Magn Reson Imaging; 2020 Aug; 52(2):589-595. PubMed ID: 32061002
[TBL] [Abstract][Full Text] [Related]
7. Dynamic contrast-enhanced mammography and breast MRI in the diagnosis of breast cancer and detection of tumor size.
Tekinhatun M; Sabir N; Erdem E; Yilmaz S; Ufuk F
Turk J Med Sci; 2024; 54(1):249-261. PubMed ID: 38812642
[TBL] [Abstract][Full Text] [Related]
8. High-temporal resolution DCE-MRI improves assessment of intra- and peri-breast lesions categorized as BI-RADS 4.
Liu Y; Wang S; Qu J; Tang R; Wang C; Xiao F; Pang P; Sun Z; Xu M; Li J
BMC Med Imaging; 2023 Apr; 23(1):58. PubMed ID: 37076817
[TBL] [Abstract][Full Text] [Related]
9. Computer-Aided Diagnosis in Multiparametric Magnetic Resonance Imaging Screening of Women With Extremely Dense Breasts to Reduce False-Positive Diagnoses.
Verburg E; van Gils CH; Bakker MF; Viergever MA; Pijnappel RM; Veldhuis WB; Gilhuijs KGA
Invest Radiol; 2020 Jul; 55(7):438-444. PubMed ID: 32149858
[TBL] [Abstract][Full Text] [Related]
10. Short-term follow-up of contrast-enhanced mammography lesions after negative breast MRI in women with elevated breast cancer risk.
Coffey K; Dixon LB; Sevilimedu V; Jochelson MS; Sung JS
Eur J Radiol; 2023 Nov; 168():111097. PubMed ID: 37738835
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Performance in Diagnosis and Characterization of Breast Lesions: Contrast-Enhanced Mammography Versus Breast Magnetic Resonance Imaging.
Açar ÇR; Orguc S
Clin Breast Cancer; 2024 Apr; ():. PubMed ID: 38777678
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of the breast MRI Kaiser score in suspected architectural distortions and its comparison with mammography.
Aslan O; Oktay A
Sci Rep; 2024 Jan; 14(1):447. PubMed ID: 38172557
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic value of MRI for architectural distortion categorized as BI-RADS category 3-4 by mammography.
Mei H; Xu J; Yao G; Wang Y
Gland Surg; 2020 Aug; 9(4):1008-1018. PubMed ID: 32953609
[TBL] [Abstract][Full Text] [Related]
14. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Performance of MRI, Molecular Breast Imaging, and Contrast-enhanced Mammography in Women with Newly Diagnosed Breast Cancer.
Sumkin JH; Berg WA; Carter GJ; Bandos AI; Chough DM; Ganott MA; Hakim CM; Kelly AE; Zuley ML; Houshmand G; Anello MI; Gur D
Radiology; 2019 Dec; 293(3):531-540. PubMed ID: 31660801
[TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced Mammography versus Contrast-enhanced Breast MRI: A Systematic Review and Meta-Analysis.
Pötsch N; Vatteroni G; Clauser P; Helbich TH; Baltzer PAT
Radiology; 2022 Oct; 305(1):94-103. PubMed ID: 36154284
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced mammography (CEM) versus MRI for breast cancer staging: detection of additional malignant lesions not seen on conventional imaging.
Taylor DB; Burrows S; Saunders CM; Parizel PM; Ives A
Eur Radiol Exp; 2023 Feb; 7(1):8. PubMed ID: 36781808
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Performance of Contrast-Enhanced Digital Mammography versus Conventional Imaging in Women with Dense Breasts.
Moffa G; Galati F; Maroncelli R; Rizzo V; Cicciarelli F; Pasculli M; Pediconi F
Diagnostics (Basel); 2023 Jul; 13(15):. PubMed ID: 37568883
[TBL] [Abstract][Full Text] [Related]
19. The Kaiser score reliably excludes malignancy in benign contrast-enhancing lesions classified as BI-RADS 4 on breast MRI high-risk screening exams.
Milos RI; Pipan F; Kalovidouri A; Clauser P; Kapetas P; Bernathova M; Helbich TH; Baltzer PAT
Eur Radiol; 2020 Nov; 30(11):6052-6061. PubMed ID: 32504098
[TBL] [Abstract][Full Text] [Related]
20. The value of noncontrast MRI in evaluating breast imaging reporting and data system category 0 lesions on digital mammograms.
Zhang R; Xu M; Zhou C; Ding X; Lu H; Ge M; Du L; Bu Y
Quant Imaging Med Surg; 2022 Aug; 12(8):4069-4080. PubMed ID: 35919041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
